Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations

The number of people with glaucoma worldwide in 2010 and 2020

Harry A. Quigley · British Journal of Ophthalmology · 2006 · 7.4K citations · Full text

Medicine, Ophthalmology, Vision Science +14

A 5-Year, Multicenter, Open-Label, Safety Study of Adjunctive LatanoprostTherapy for Glaucoma

Albert Alm · Archives of Ophthalmology · 2004 · 86 citations

Medicine, Ophthalmology, Vision Science +16

Drug patent expirations and the speed of generic entry.

Jung-eun Bae · PubMed · 1997 · 74 citations

Pharmacy, Pharmaceutical Policy, Pharmacology +15

A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan ® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension

Arun Narayanaswamy, Aditya Neog, Mani Baskaran et al. · Indian Journal of Ophthalmology · 2007 · 68 citations · Full text

Medicine, Ophthalmology, Pharmacology +15

pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.

William F. Brechue, T. H. Maren · PubMed · 1993 · 50 citations

Medicine, Ophthalmology, Pharmacology +17